Medications for Acute Coronary Syndromes
KEYWORDS: patients, orally, risk, heparin, pci, day, used, hours, bleeding, given, nitroglycerin, therapy, coronary, use, acs

is Atenolol Variable† not tolerated or is contraindicated, especially high-risk patients; used long-term Bisoprolol Variable† Intravenous beta-blockers may be used in patients with ongoing chest pain despite usual measures, or persistent tachycardia, or Carvedilol Variable† hypertension in patients with unstable angina and myocardial infarction. Caution is necessary in patients with hypotension Metoprolol Variable† or other evidence of hemodynamic instability. Calcium channel blockers Amlodipine Variable† Patients with stable angina if symptoms persist Diltiazem (extended- Variable† despite nitrates use or if release) nitrates are not tolerated Felodipine Variable† Medication Dosage Use Nifedipine (extended- Variable† release) Verapamil (extended- Variable† release) Glycoprotein IIb/IIIa inhibitors Some patients with ACS, Abciximab Variable† particularly those who are having PCI with stent placement and high-risk patients with unstable Eptifibatide Variable† angina or NSTEMI and large thrombus burden Therapy started during PCI Tirofiban Variable† and continued for 6–24 hours thereafter Nitrates: Short acting All patients for immediate Sublingual nitroglycerin 0.3–0.6 mg every 4–5 relief of chest pain; used (tablet or spray) minutes up to 3 doses as needed Selected patients with ACS: During the first 24 to 48 hours, those with heart failure (unless hypotension is present), large anterior myocardial Started at 5 mcg/minute infarction, persistent Nitroglycerin as and
